Flerie is a proactive, long-term investor in the life sciences sector, specializing in biotech and pharmaceutical investments on a global scale. Headquartered in Stockholm and London, Flerie oversees a diverse portfolio of more than 30 investments spanning across Europe, Israel, and the US. Their mission is to empower innovative organizations primarily in drug development and related services, offering essential resources and expertise to foster success. Flerie manages assets totaling over SEK 3,000 million across three distinct segments: Product Development, Commercial Growth, and Limited Partnerships.